Page 9 - Zydus Cadila

Zydus Cadila gets USFDA's final approval to market antidepressant drug

The drug, used in treating depression, will be manufactured at the group's formulations facility at SEZ Ahmedabad

Zydus Cadila gets final nod from USFDA for doxycycline tablets

The company will manufacture the drug at the group's formulations facility at the pharma SEZ in Ahmedabad

Zydus Cadila gets final US FDA nod to market arthritis drugs

It will manufacture the drug at the Moraiya facility in Ahmedabad

Zydus Cadila gets USFDA nod to sell hypertension drug

The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applications

Zydus and Pharm Aid tie up for vaccine technology for Russia

Cadila Healthcare Limited (Zydus Cadila), has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd, headquartered in Russia. Pharm Aid Ltd, has been set up by Nacimbio together with Ishvan Pharmaceuticals Ltd, for the localisation of innovative vaccine production in Russia. Pharm Aid Ltd was set up in May 2017 as a joint venture of Russian National Immunobiological Company (Nacimbio) that represents the pharmaceutical group of Rostec State Corporation and Ishvan Pharmaceutical Ltd from UAE in 51-49 ratio. The company aims to partner with leading global pharma companies and bring in affordable, innovative products and full-cycle technology to the Russian Federation in treatment areas of Vaccines, HIV, Hepatitis and Tuberculosis. The exclusive agreement was signed at the BIOTECHMED conference in Gelendzhik, Russia. "We welcome this opportunity to participate in and partner biotech opportunities in

Zydus Cadila gets US health regulator nod to market Mycophenolate Mofetil

The group now has more than 140 approvals

Zydus Cadila gets USFDA nod to market anti-dementia drug

Group now has around 140 approvals and has so far filed over 300 abbreviated new drug applications

Zydus Cadila gets USFDA nod for drug used to reduce risk of strokes

Zydus Cadila will manufacture drug at its formulations manufacturing facility

Zydus gets audit report of Ahmedabad-based SEZ plant from USFDA

Inspection was conducted during January in 2017

Zydus Cadila receives USFDA approval to market blood pressure drug

This drug, diltiazem hydrochloride' is also prescribed for angina and certain heart rhythm disorders

Zydus Cadila gets USFDA nod for high blood pressure, heart disorder drug

The hypertension drug is used to treat chest pain, certain heart rhythm disorders

USFDA approves Zydus Cadila drugs for brain tumour, hypertension

Temozolomide is a chemotherapy drug used in the management of brain tumours

Zydus Cadila gets USFDA approval for colitis drug; margins get a boost

Currently, it sells the authorised generic version of Asacol HD in the US

'Some gaps in the emerging markets portfolio, but not very significant'

Pankaj R Patel is passing on the baton of Zydus Cadila to his 38-year-old son Sharvil Patel

Zydus begins Phase-II trials for its new anaemia drug Zyan1

Developed drug, an oral molecule, is the latest new chemical entity from the firm's pipeline

Zydus Cadila gets US FDA approval to market generic Hepatitis B drug

The Ahmedabad-based group has now more than 120 approvals from the USFD

FDA nod for generic Lialda launch to boost US biz for Zydus Cadila in FY18

Market for the drug, which could be a key growth driver for firm's US business, is pegged at $1.1 bn

US court rules in favour of drug firm Zydus Cadila in patent case

The Court of Appeals' decision is a major step toward Zydus providing a generic version of Lialda

Zydus subsidiary receives USFDA nod to market Tamiflu drug

Group also received approval for antibiotic Linezolid tablets in the strength of 600 mg

Coming soon: A seasonal flu fighting vaccine in India

The vaccine provides protection from four influenza viruses -- H1N1, H3N2, Type B (Brisbane)